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Summary: Several proposed theories have described the progression of HIV infection.
Even so, no concrete evidence supports any as comprehensive, including, for example,
why the CD4+ T-cell counts fall from 1000/mm3 of blood to roughly 100/mm3 over an
average 10-year period, whereas concomitant viral loads are relatively constant, in-
creasing by several orders of magnitude in late-stage disease. Here, we develop and
validate a theoretical model that altered lymphocyte circulation patterns between the
lymph system and blood due to HIV-induced enhanced lymph-node homing and sub-
sequent apoptosis of resting CD4+ T cells can explain many aspects of HIV-1 disease
progression. These results lead to a recalculation of the CD4+ lymphocyte dynamics
during highly active antiretroviral therapy, and also suggest new targets for therapy.
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The mechanism by which HIV causes depletion of
CD4+ lymphocytes in infected individuals remains un-
clear, and even the extent of CD4+ T-cell elimination per
unit of time is controversial. Several theories have been
posited to explain this process (1–6). Any theory or
model should reconcile the following hallmarks of the
disease process.
Net loss of blood CD4+ lymphocytes is gradual and
takes, on average, 10 years.
CD4+ T-cell counts decrease proportionally in the blood
much earlier than in lymph nodes, and in the early
asymptomatic stages when most CD4+ lymphocytes
are declining in the blood, their numbers concomi-
tantly and transiently increase in the lymph nodes
(lymphadenopathy) (7,8).
Compartmentalization of HIV-infected cells to lym-
phatic tissues occurs within which the preponderance
of virus-producing cells reside, together with most of
the virus in the body (trapped on follicular dendritic
cells [FDCs]) (9,10).
The number of productively-infected cells at any time is
very low, in a ratio to uninfected cells at 1:105 (with
approximately 107 productively infected cells present
in the whole body from a total of 1012 lymphocytes)
(9,11).
The CD4+ lymphocytes that die do so in lymph nodes,
not in the blood, and most that die are bystander cells
(i.e., not producing virus) (12–17).
Our work focuses on lymphocyte dynamics during
HIV-1 infection. The factors determining this can be
classified into three main areas: changes in cell produc-
tion, changes in cell life-spans, and changes in cell mi-
gration patterns. Addressing the first hallmark given,
namely the decline of CD4+ lymphocytes in the blood
during HIV infection, three possible mechanisms for
their loss exist: new CD4+ lymphocytes are not being
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generated at or above their normal rate; CD4+ T cells are
being killed in the blood and cleared (whether by virus or
cytotoxic T lymphocytes [CTLs] is not clear); or circu-
lation patterns of CD4+ T cells in the blood are altered by
increased homing out of blood into tissues.
Solid data support the first and last of these hypoth-
eses, namely that loss of CD4+ lymphocytes in the blood
may be due to both retarded production of CD4+ T cells
and altered circulation patterns together with aberrant
signaling leading to the induction of apoptosis. Data con-
firming these were recently published demonstrating that
after 6 months of highly active antiretroviral therapy
(HAART) there was an increase in new, naive CD4+ T
cells (18), whereas the early return of CD4+ T cells fol-
lowing HAART appears to be due to redistribution (19).
Furthermore, abortive HIV infection of resting lympho-
cytes leads to their upregulation of L-selectin (CD62L),
the receptor on lymphocytes that is involved in homing
to lymph nodes, and these cells displayed strong lymph-
node homing properties (20,21). These cells demon-
strated an approximately 12-fold increase in the ability to
bind to high endothelial venules on frozen sections of
lymph nodes, and when injected into the blood of mice
infected with severe combined immunodeficiency syn-
drome (SCID), approximately 70% homed from the
blood compartment into lymph nodes within 2 hours
(20,21). Further studies have shown that a large propor-
tion (roughly half) of the cells that are induced to home
through HIV binding, undergo apoptosis after they enter
the lymph node (21). This results from secondary sig-
naling of these cells through the homing receptors
(CD62L, CD44, CD11a). These cells were shown to die
without producing HIV. These cells that bind virus, but
do not contain integrated viral DNA, are considered
abortively infected. These cells fit the classical definition
of abortive infection because virus binds and enters rest-
ing CD4+ cells and partially (or completely) reverse tran-
scribes RNA into DNA, but the DNA does not integrate.
Chun et al. (11) referred to these cells as preintegration
latent; however, the classical definition of viral latency
refers to a virus that can turn on and off its expression.
Other studies have shown that classical latent infection
occurs with HIV only after productive infection has oc-
curred, and that these latently infected cells can be reac-
tivated to productive infection.
Use of experimental models is relevant to correspond-
ing processes occurring in humans. In two studies by
Wang et al. (20,21), signaling of resting CD4+ cells in
culture was performed with HIV or, in the case of the
homing receptors, with monoclonal antibody cross-
linking or with their natural ligands. It is widely accepted
that such signals mimic signaling of the same receptors
in vivo. This is especially true when natural ligands are
used in the in vitro studies. Those works also show that
signaling through the homing receptors of HIV-bound
cells induces many of them to die, whereas signaling of
the homing receptors of normal lymphocytes does not.
Presumably, this reflects what occurs in HIV-infected
patients. Confirming the in vitro results, these same stud-
ies also show that “HIV-signalled” resting human CD4+
cells placed into the blood of SCID mice home at en-
hanced rates to the lymph nodes, and a large number die
after entering the lymph node. SCID mouse studies of
lymphocyte trafficking are considered relevant to normal
homing processes, as homing receptors and homing pro-
cesses are conserved among mammals. To show that
these processes do actually occur in HIV-infected pa-
tients, in vivo studies have been performed that have
been submitted soon for publication. These studies dem-
onstrate that CD4+ lymphocytes in HIV-infected patients
home to lymph nodes 2–3 times faster than CD4+ lym-
phocytes in uninfected individuals. Thus, in vitro and
SCID mouse studies of Wang et al. (20,21) have now
been confirmed in patients.
These cited studies (20,21) indicate that apoptosis oc-
curs in HIV-signaled cells because of induction of Fas
ligand following signals through homing receptors. Such
signals normally occur on all cells homing into lymph
nodes. Cloyd’s unpublished data indicate that signaling
through various homing receptors including L-selectin,
integrins, or CD44, all induce upregulation of Fas ligand.
Normally, naive or memory resting cells that are homing
do not express Fas, and therefore induction of Fas ligand
does not lead to apoptosis. What is abnormal with HIV-
signaled cells is that they have upregulated Fas expres-
sion and thus homing can lead to apoptosis.
This enhanced homing and increased susceptibility to
apoptosis may explain the bystander-cell effect that has
been observed in lymph nodes of patients (12–17). These
ideas are also supported by histologic studies showing
that CD4:CD8 ratios do not change in lymph nodes co-
incident with changes in the blood ratios (7,22,23). In
addition, enhanced homing supports the observation that
in the early stages of HIV infection, the numbers of
CD4+ lymphocytes often increase in the lymph nodes
(lymphadenopathy) with a concomitant decrease in
blood (7,24).
We therefore test the hypothesis that the decline in
CD4+ T-cell counts in blood is due to altered lymphocyte
circulation patterns resulting from HIV-induced homing
of CD4+ T cells to lymph system, most of which are
resting cells. One premise of this discussion is that the
lymph system (LS) and blood do not operate in parallel
as previously thought (6,22), but rather, although the
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blood viral load grows, the LS viral load saturates early
in infection. Using this hypothesis as a new premise ex-
plaining the disappearance of CD4+ lymphocytes from
the blood, a model for the dynamics of lymphocyte turn-
over can be developed. Figure 1 diagrams these pro-
cesses and is explained as follows. The model, validated
against data, is used to generate new calculations on
CD4+ lymphocyte dynamics during HAART.
HIV is produced primarily in the lymph nodes, be-
cause this is where most lymphocytes, and hence pro-
ductively infected cells, reside. Newly produced virions
bind to surrounding CD4+ lymphocytes and follicular
dendritic cells (FDCs); given that only 1% to 2% of
lymphocytes are activated (25), most virions interact
with resting lymphocytes. After FDCs have become satu-
rated with virus, the newly formed virions presumably
flow out to the blood. Recent evidence suggests that
virus can be released from FDCs (9,10), supporting this
hypothesis. Many abortively infected CD4+ T cells re-
circulate back into the blood within 1 to 2 days through
normal lymphatic circulation patterns. Abortively in-
fected T lymphocytes then home into lymph nodes at an
enhanced rate, thus accounting for the gradual disappear-
ance of the CD4+ lymphocytes in the blood. A portion of
the CD4+ T lymphocytes that survive may enter the cell
cycle if signaled within a short time frame, at which
point they can produce virus. Thus, as more of these cells
home into lymph nodes, greater numbers of productively
infected cells result, and HIV levels in the body continue
to rise. This in turn induces a cyclic pattern whereby
constant, or increasing, numbers of CD4+ lymphocytes
home from the blood into lymph nodes, a portion of
which die during homing (Fig. 1).
MODEL DEVELOPMENT
Lymphocyte Circulation
We first describe normal lymphocyte circulation be-
tween the blood and lymph system in a healthy indi-
vidual (26). There is unidirectional continuous flow of
lymphocytes between blood and the LS. T cells in blood
normally flow into the LS through a precisely controlled
process (homing) and then, through the thoracic duct at
the superior vena cava, they flow back into the blood.
Classical experiments on lymphocyte circulation indicate
that when the thoracic duct is cannulated and cells are not
allowed to recirculate, the lymph nodes deplete of lym-
phocytes within 2 days (27–30). These studies indicate
that lymphocytes cycle through this system approxi-
mately once daily (23,27,31,32). Thus, inasmuch as only
2% of all lymphocytes are in the blood at any time, the
average transit time through the blood must then be ap-
FIG. 1. Virus-lymphocyte inter-
actions and lymphocyte circula-
tion in the blood and lymph nodes.
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proximately 30 minutes, with the remainder of the 1-day
circulation time being spent within the LS.
Patterns of cell trafficking during HIV infection are
altered. In HIV-infected patients, normal trafficking of
naive CD4+ lymphocytes and L-selectin-high memory
cells (none of which have come in contact with HIV)
migrate from the blood into lymph nodes and lymphoid
tissues and if they do not encounter antigen, migrate back
into the blood within a day or two, as in uninfected
individuals. The time spent in the blood is approximately
30 minutes. However, any resting CD4+ lymphocyte in
the lymph nodes that comes in contact with HIV-
producing cells, free virions, or HIV-coated follicular
dendritic cells can be signaled by HIV gp120 through its
CD4+ receptor and upregulation of expression of homing
receptors is thus induced. This increased expression of
L-selectin maximizes at 36 to 40 hours after contact, at
which time most of these resting cells will have migrated
into the blood stream (20,21 and unpublished data).
These cells then home back into the lymph nodes at
enhanced rates, and during homing may receive second-
ary signaling that can induce approximately half (or
more) of the cells into apoptosis.
To model this complex system of HIV-lymphocyte
interactions mathematically, it is necessary to consider a
two-compartment model including both blood and LS.
Our goal is to explain the progression of HIV disease
based directly on the effects HIV has on CD4+ T-cell
dynamics but only indirectly on the viral dynamics them-
selves. A more detailed model is forthcoming from our
group that also examines viral dynamics. We consider
the simplest interactions in each of the two compart-
ments, blood and LS, as suggested by the diagram in
Figure 2.
Model Equations
To model the cell population dynamics within each of
these two compartments, we first divide the total popu-
lation of CD4+ T cells into those in the blood and those
in the LS. We define two populations in the blood: Tp(t),
the total number of uninfected CD4+ T cells in the blood,
and TlP(t), the total number of latently infected CD4
+ T
cells in the blood. These latently infected cells differ
from abortively infected cells in that the viral DNA has
been integrated into the host genome and, if these latent
cells become activated by antigen presentation and enter
the cell cycle, they can produce virus. We define four
populations in the lymph system each measured in total
number of cells: TL(t), the uninfected CD4
+ T cells, TaL(t),
the abortively infected cells, TlL(t), the latently infected
cells, and TlL(t) the activated, productively-infected cells.
FIG. 2. A two-compartmental
model of the dynamics of CD4+ T
cells during HIV-1 infection.
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Some key assumptions for the models are as follows.
First, experimental evidence indicates that the immune
system has the capacity to sense and respond to a reduced
level in the total CD3+ T-cell population, but not to re-
duced levels of the specific CD4+ T-cell subset (33,34).
We assume that the rate of production and the rate of loss
of uninfected CD4+ T cells is maintained in equilibrium.
Thus, in the model, no source terms or loss terms exist
for CD4+ T-cell populations, except the small loss due to
HIV infection (including abortive, latent, and productive
infection). Therefore, the model could account for a less-
than-normal, normal, or more-than-normal cell turnover.
This simplification also implies, however, that lymph-
adenopathy will not be observed in our model. Future
models will be more comprehensive.
Second, based on normal lymphocyte circulation pat-
terns, we assume uninfected and latently infected T cells
spend 1 day in the LS and 0.5 hours in the blood (27,28).
Abortively infected cells home to the LS at an enhanced
rate, where as many as 50% are induced into apoptosis
and the rest revert to the uninfected class after several
days and rejoin normal circulation (21). This follows
given that unintegrated viral DNA has a short half-life
(35).
Third, we assume that most productively infected cells
are in the LS; and that, because their lifespan is short,
few circulate out to blood. Thus, we do not monitor the
productively infected population nor the abortively in-
fected cells in the blood. Because >99% of the virus-
producing cells are in the LS, nearly all estimated 109–
1010 virions (6,36) produced per day must therefore be
made in the LS. Consequently, most infection takes place
in the LS.
The model equations are:
dTP
dt
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The viral-immune interactions outlined in Equations 1
through 6 are explained as follows. Equation 1 tracks the
change in the uninfected, blood CD4+ T-cell population.
Because only a small fraction of lymphocytes are present
in blood at any given time, the source and loss of cells
from this compartment are reflected solely through lym-
phoid compartmental recirculation patterns. The first
term is the source of cells from the LS, and the second
term is the loss of cells from the blood as they circulate
into the lymph system. Equation 2 represents the change
in the population of latently infected cells in the blood.
Latently infected cells circulate in fashion similar to that
of the uninfected cells between blood and lymph, hence
TABLE 1. Parameter values with corresponding references in parentheses
Definition Value [reference] Units
Initial size
TP(0) Uninfected blood CD4
+ T cells 2% of TL(0) /total blood
T lP(0) Latently infected T cells in blood 0.0 /total blood
TL(0) Uninfected lymph CD4
+ T cells 2.0 ! 1011 (50) /total lymph
TlL(0) Latently infected T cells 0.0 /total lymph
TaL(0) Abortively infected T cells 0.0 /total lymph
T iL(0) Actively infected T cells 0.0 /total lymph
Parameters
cL Circulation rate of cells out of LS into blood 1.0 (27–30) /day
cP Circulation rate of cells out of blood into lymph system 50.0 (27–30) /day
k Infection rate of CD4+ T cells by virus 0.001 /day
p Proportion of infected cells that are latently infected 0.01 (11) scalar
q Proportion of infected cells that are activated 0.02 (25) scalar
sl Rate latently infected cells activate 0.03 /day
si Rate actively infected cells shut down 0.01 /day
r Proportion of abortively infected cells that survive 0.47 (21) scalar
!a Conversion of abortively infected T cells 0.2 (35) /day
!i Death rate of productively infected T cells 0.5 (36) /day
!l Death rate of latently infected T cells 0.01 (51) /day
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there are gain and loss terms representing exchange
terms that are opposite in sign to those in Equation 4.
Equation 3 monitors the change in the CD4+ T-cell popu-
lation in the lymph system. The first two terms are the
same, but opposite in sign, to those in Equation 1 for
blood T cells. This reflects the equivalent exchange of
cells between compartments resulting from circulation.
The third term reflects a loss of cells in the uninfected
class due to infection, at rate k. Because we do not model
the viral dynamics directly, we approximate this infec-
tion rate as a daily percentage of the CD4+ T-cell popu-
lation. The final term of Equation 3 is a gain term, at rate
!a, of abortively infected cells that, after several days,
regain uninfected status when the unintegrated, unstable
viral DNA degrades (35).
The source terms for the infected-cell equations each
are a proportion of the infection process in Equation 3,
namely !kTL(t). We assume that infection of cells is
divided into four classes. The first, a proportion p, are
latent infections (the first term of Equation 4). The sec-
ond, a proportion q, are actively infected (the first term in
Equation 6). The remainder comprises abortive infec-
tions and a proportion r reverts to the uninfected state
after 1/!a days, and (1 ! p ! r ! q) home to lymph nodes
and undergo apoptosis within 1 to 2 days (20,21). Equa-
tion 5 marks the change in the abortively infected T-cell
population. The first term is the gain due to infection,
and the second term reflects the loss due to either con-
version back to the uninfected state and includes the loss
of cells due to apoptosis. Finally, Equation 6 represents
the change in the productively infected T-cell population
in the LS. The first term is the source due to infection,
followed by a short life-span loss term. The last terms
represent an exchange from the activation state either to,
or from, the latent state in opposite sign to Equation 4.
Parameter Estimates
To present a mathematical model accurately, we must
also estimate parameter values and initial population
starting points for the rate constants and cell populations
in the model. These parameters are the rate constants of
the processes outlined in Equations 1 through 6. We note
that the infected populations begin at 0, given that we
initiate the model at the inoculum. We also note that the
model is robust for small changes in these parameter
values, and these small changes would not qualitatively
affect the model outcomes. A summary of the parameters
and their values is presented in Table 1.
MODEL VALIDATION AND PREDICTIONS
The key purpose of developing a mathematical model
to describe the lymphocyte-pathogen interactions we
have outlined is to test whether these hypotheses can
yield the disease observations and thus lend insight into
the pathogenic mechanisms of HIV. We can then use the
model to test theories associated with our hypotheses,
such as turnover rates and the like. To this end, we solve
the model system; the results are given in Figure 3. Be-
havior in both the blood and lymph compartment over an
average of 7 years is consistent with experimental and
clinical data for HIV-infected patients during the same
time period (11,20,21,33,34,37). Panel A of Figure 3
presents data from three clinical studies representing the
typical progression of T-cell loss in the blood during
HIV infection, with the results of the model (solid line)
given for direct comparison (33,34,37).
Table 2 presents the comparison of the model simula-
tion with proportional data for each class of infected
cells; namely, the productively infected (active and pro-
ducing virus), latently infected (provirus), and abortively
infected CD4+ T cells in blood and the lymph system.
Again, the model is consistent with experimental data
(11). In the simulation, the overall rate of CD4+ T-cell
depletion in the blood is approximately 106 per day (not
shown). This corresponds to calculations made from val-
ues reported by Wolthers et al. (38).
Apoptosis of Abortively Infected Cells
Depletion of CD4+ lymphocytes in the LS during pro-
gression is due primarily to apoptosis of abortively in-
fected cells. The effect of this loss can be gauged by a
sensitivity analysis of the parameter r, corresponding to
the survival fraction of abortively infected cells. As seen
in Figure 3B, the population of uninfected CD4+ lym-
phocytes in the LS falls to approximately 15% of normal
over a 10-year progression. The rate of decline depends
on the value of r, as seen in Figure 4. As the survival
fraction r increases to its maximum possible value, the
population of uninfected CD4+ lymphocytes in the LS
falls to approximately 90% of normal during a 10-year
progression. The model is thus consistent with an expla-
nation of CD4+ lymphocyte depletion in the LS during
progression as a result of the loss of abortively infected
cells, and not as a result of an impairment of the source
of uninfected cells.
CD4+ Lymphocyte Dynamics During Highly Active
Antiretroviral Therapy
Previously published estimates of numbers of CD4+
lymphocytes that turn over per day were based on the
daily rates of CD4+ lymphocyte return to the blood fol-
lowing HAART (5,39). The assumption was made that
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the returning cells represent those that would be killed
without therapy. Of course, in the small sample size,
some individuals had a rate of return that was extremely
small whereas in other patients it was more significant.
Both of these studies (5,39), indicated that between 5 and
8 cells/mm3 per day were returning in study subjects with
a good response rate, giving a total of approximately 3 "
107 CD4+ lymphocytes returning per day in the total 5 L
FIG. 3. Model solutions for both blood (A) and lymph (B) compartments (solid curves). Data showing the average time series of CD4+
T-cell loss in blood during HIV-1 infection from three studies (37), ! (33), and ! (34). The model results are presented for direct
comparison with peripheral data. (C–F) are the time courses for the latently infected cells in the blood (TPL), and the latently infected,
actively infected and abortively infected cells in the lymph node, respectively. See Table 2 for comparison with other known ratios. Note
that no time series of the kind shown in (A) is available for the LS cell dynamics.
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blood. Even though these measurements were made un-
der quasi–steady-state assumptions on the target cell
population (implying that the results hold true for a short
time scale) and that the lymphocytes in the blood reflect
only 2% of the total body lymphocytes, the same loss
rate was then extrapolated to the whole body, for the
whole life-span of the infection. This led to the estimates
of approximately 2 " 109 lymphocytes being destroyed
per day in an HIV-infected person (5,39).
These calculations done in studies by Ho et al. and
Wei et al. (5,39) were based on three hypotheses that had
not been formally verified by data: disappearance of
CD4+ lymphocytes in the blood is equated to their death;
the number of CD4+ lymphocytes that return on therapy
is equal to the number that normally die in an untreated
individual; and changes in the numbers of CD4+ lym-
phocytes in the blood can be extrapolated to CD4+ lym-
phocytes throughout the body. Our theoretical model,
together with our experimental data (20,21), would sug-
gest that these three hypotheses are incorrect. The phe-
nomena observed can instead be explained as follows.
Disappearance of CD4+ lymphocytes in the blood is due
to altered circulation properties and enhanced homing
of cells and not to a high rate of cell turnover. Al-
though our data indicate that at least half the cells that
are abortively infected and induced to home to the LS
are further induced into apoptosis inside the lymph
nodes, our model also suggests that some survive and
a small fraction of these will become virus-producing
cells (21).
The CD4+ T-cell increase in the blood that occurs during
HAART is due to termination both of HIV-induced
homing and a return to normal circulation patterns as
well as production of new cells (18,19,40). This fol-
lows from the finding that in general, memory T cells,
(CD45R0+), do not circulate through normal lymph
node circulation patterns as naive cells (CD45RA+)
do; however, our studies indicate that both naive and
memory cells are induced by HIV-binding to home to
lymph nodes (20). Thus, when HAART is adminis-
tered, it is the memory cells that cease to home, and it
is memory cells that have been shown disproportion-
ately to return to blood after HAART (41). These cells
would also have the greatest capacity to respond to
antigen presentation and clonally expand.
The change in the numbers of CD4+ lymphocytes in the
blood should not be extrapolated to the whole body,
because enhanced homing will increase redistribution
of CD4+ lymphocytes into the LS at the expense of the
blood; and at least during infection, these compart-
ments are not in parallel (19,40). In addition, early-
infection lymphadenopathy indicates that while lym-
phocytes are decreasing in the blood, they coinciden-
tally rise in the lymph nodes.
In our model, simulation of HAART shows a small
rebound to a steady state in which cells level off below
their normal, uninfected levels (not shown). No rebound
above this level is seen given that we do not include a
source of new naive cells into the blood and LS. If we
include this source of new cells, we can obtain rebounds
as observed in studies by three separate groups led by
Hellerstein, Bucy, and Pakker (18,19,40).
Recalculation of Cell Dynamics
Using the three premises just stated, recalculation of
the number of CD4+ lymphocytes that die per day can be
made. First, from published data (5,39) the numbers of
cells that return on HAART range widely from 4 " 106
! 1.08 " 108 total per day in the blood. These values are
inversely correlated to stage of infection, with the lower
values corresponding to pre-AIDS blood CD4+ T-cell
counts. In our model, a typical pre-AIDS count is ap-
proximately 500/mm3 at 3 years after infection, at which
time the total number of abortively infected cells in the
body is between 108–109 cells and productively infected
cells number approximately 106–107 at any given time.
Before HAART, the abortively infected cell compart-
ment, TaL(t) is in relative equilibrium. After HAART, the
TaL(t) compartment empties as the abortively infected
cells revert to the compartment of uninfected cells in the
LS, TL(t). These cells spend approximately 2% of their
time in the blood compartment Tp(t). Thus, 2 " 10
7 total
cells appear in the blood after HAART, or about 4 "
106/day, which corresponds to the lower value given by
Ho et al. (5). Release and altered circulation of abortively
infected cells can therefore account for the observed in-
crease of cells in the blood during HAART, at least be-
fore the onset of the final AIDS collapse of the CD4+
T-cell population.
Because of the extremely high numbers of cells turn-
TABLE 2. Model simulation values compared with data from Chun
et al. (11)
Proportion of infected




cells in lymph system TiL/TL " 0.01% 0.02%
Latently infected cells
in lymph system TlL/TL " 0.03% 0.01%
Abortively infected cells
in lymph system TaL/TL " 0.3% 0.5%
Latently infected cells in blood TlP/TP = 0.03% 0.01%
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ing over per day in the previous models (5,39), the as-
sumption had to be made that cell renewal occurs widely
on a daily basis; otherwise a patient would advance to
AIDS in a matter of weeks. With our model of disease
progression, the assumption of an extremely high re-
newal of cells is not necessary. Instead, our model, which
makes no assumptions about CD4+ T-cell renewal, as-
sumes instead that there is a gradual net loss of a small
number of cells daily due to infection that over a 10-year
time-span leads to eventual elimination of most CD4+
lymphocytes in the blood. This idea is consistent with
earlier and more recent studies (18,41), which demon-
strate that the half-life of CD4+ T cells in blood of late
stage HIV-positive patients is about one-third normal
and is not compensated by a major increase in the abso-
lute production rate.
In addition, only a small fraction of virus-producing
cells is needed to account for the estimated amounts of
HIV produced per day (109–1010 virions) (36), given that
one productively infected cell produces 102 to 103 viri-
ons/24 hours (10,42,43). Thus, approximately 107 pro-
ductively infected cells out of 1012 total lymphocytes in
the whole body should suffice to produce the observed
amounts of virus.
DISCUSSION
Our mathematical modeling combined with experi-
mental evidence (20,21) supports the scheme presented
in Figure 1 as a major mechanism of HIV pathogenesis.
The effects of HIV (induction of lymph-node homing,
and apoptosis after entering the lymph nodes) on resting
T lymphocytes can explain the depletion of CD4+ T lym-
phocytes from the peripheral blood when few blood
CD4+ lymphocytes are productively infected. It also can
help explain end-stage depletion of CD4+ T lymphocytes
from the lymph nodes. One consequence of viral induced
homing is that it correlates directly with the amount of
virus present in the LS. As the disease stage progresses,
this viral load should increase, and hence even greater
amounts of homing and apoptosis occur. Thus, this idea
is consistent with late-stages of disease with low T-cell
counts in the blood and high viral loads (which are pro-
duced in the lymph nodes).
This model of HIV disease also allows reexamination
of the rates of cell production and turnover during infec-
tion. It lends insight into the dynamics seen during treat-
ment with HAART, which is important for understand-
ing the effects of chemotherapy. Given that latently in-
fected cells are unaffected by therapy but do harbor
provirus, and that these cells can later reactivate and
reestablish infection; they can play a key role in the
success or failure of treatment.
The thymus plays an important role in HIV-1 disease
progression (44–47). It may serve as a source of both
virus and infected cells, thus augmenting systemic infec-
tion (44). However, if the thymus retains its function
during infection, it can then continue supplying lympho-
FIG. 4. Graphs of the values of the
uninfected and infected CD4+ lym-
phocyte populations in the blood
and lymph system after 10 years
of disease progression as a func-
tion of the parameter r (the propor-
tion of abortively infected cells that
do not undergo apoptosis). A typi-
cal progression (as seen in Fig. 3
with r = 0.5) corresponds to a
depletion of CD4+ lymphocytes in
the LS to approximately 15% of
normal at 10 years. As r increases
to 1, the population of uninfected
CD4+ lymphocytes in the lymph
system at 10 years approaches
approximately 90% of normal.
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cytes to the blood, potentially slowing disease progres-
sion (47). In our model, turnover of CD4+ T cells is in
balance except for the loss due to HIV infection. If a
compartment is added to the model to represent the thy-
mus, then the progression to AIDS is augmented if the
thymus is also a source of virus and infected cells; how-
ever, a functional thymus can slow the progression by
supplying new lymphocytes to blood. Thus, our model is
consistent with the known effects of the thymus in HIV
pathogenesis (45,46).
Moreover, other markers of disease progression exist
in HIV aside from CD4+ T-cell depletion that includes
viral coreceptor usage, replication kinetics, immune re-
sponse effects, and the like. However, we have simpli-
fied our model to study only the effects of enhanced
homing. Certainly, a more complex model incorporating
these other mechanisms would serve to refine the model
further, because although we believe enhanced homing is
a key mechanism of HIV pathogenesis, it does not op-
erate alone. Future work will attempt to explore these
combined issues.
The model generated by our mathematical description
of these processes shows that this small loss would lead
to a net decline of CD4+ lymphocytes of approximately
100 cells/mm3/year leading to the almost complete loss
of CD4+ lymphocytes after 10 years. This model likely
presents a more accurate picture because it is based on
experimental data about what HIV does to resting lym-
phocytes (the majority), and this model can predict key
hallmark features of HIV infection. Others have also hy-
pothesized that an imbalance in homeostasis as well as
cell redistribution may be responsible for HIV dynamics
supporting our theory (48).
As treatment strategies for HIV infection encounter
increasing problems due to both the development of drug
resistance and residual replication in latent cells (49,50),
new approaches are urgently needed. Therapeutic ap-
proaches involving inhibition of viral-induced homing
and/or homing-induced apoptosis, in conjunction with
treatments that inhibit viral replication, may prove ben-
eficial for HIV-infected study subjects.
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